How to Buy Zentalis Pharmaceuticals Stock
Zentalis Pharmaceuticals Inc
Zentalis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers.
Zentalis Pharmaceuticals stock last closed at $11.31, up 2.26% from the previous day, and has decreased 48.38% in one year. It has underperformed other stocks in the Biotechnology industry by 0.27 percentage points. Zentalis Pharmaceuticals stock is currently +18.31% from its 52-week low of $9.56, and -64.05% from its 52-week high of $31.46.
As of May 1, 2024, there are 70.96M ZNTL shares outstanding. The market value of ZNTL is $802.56M. In the last 24 hours, 1.02M ZNTL shares were traded.
How to Buy Zentalis Pharmaceuticals Stock
Wondering how to invest in Zentalis Pharmaceuticals stock? Here's how.
- Choose where to buy Zentalis Pharmaceuticals stock: You need to choose an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you figure out where to buy Zentalis Pharmaceuticals stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Pick your payment method and add your information.
- Evaluate Zentalis Pharmaceuticals stock: The Zentalis Pharmaceuticals ticker symbol is ZNTL. Is Zentalis Pharmaceuticals stock a good investment? Should you buy shares of ZNTL? How do ZNTL's underlying business fundamentals look? Do top analysts think Zentalis Pharmaceuticals is a good buy? Why has ZNTL's stock price moved recently? (Hint: Our stock market research tools can help you understand if ZNTL is a good stock to buy).
- Place your ZNTL buy order: Decide if you will purchase ZNTL shares at the current market price or use a limit order to purchase ZNTL shares at a given price.
- Keep an eye on your ZNTL investment: Create a watchlist to monitor your position in Zentalis Pharmaceuticals shares.
Step 1: Choose where to buy Zentalis Pharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy ZNTL shares.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Healthcare, New York to London — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro now.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected your brokerage, you need to fill out some personal information so you are able to buy ZNTL today.
How to Set Up a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to open a new brokerage account.
- Send your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've opened your account on apps for stocks, you can securely and quickly fund your account:
Check out this video walkthrough to see the process of transferring funds into your new investment account.
Step 4: Evaluate Zentalis Pharmaceuticals stock
After you have chosen the best place to buy Zentalis Pharmaceuticals stock, it's critical to analyze their stock before you buy, so you actually wrap your head around the risk and opportunity.
Zentalis Pharmaceuticals shares data
ZNTL Zen Score
WallStreetZen was designed to help part-time investors do more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on ZNTL's stock page.
Is ZNTL stock properly valued?
Investors use many financial metrics, analyses, models, and charts to gauge ZNTL's intrinsic value.
Using relative valuations ratios:
- ZNTL could be undervalued based on its P/B ratio of 1.84x, relative to Biotechnology industry P/B ratio of 6.02x
You can access additional valuation research on ZNTL's stock here.
Is ZNTL a healthy company?
Positive Financial Indicators:
- There are more short-term assets than long-term liabilities on the ZNTL balance sheet.
- ZNTL has cash burn of 208405000. It has enough cash and short-term investments to cover this for at least one year.
- ZNTL has a low debt to equity ratio of 0.26.
- Total ZNTL debt is lower than 5 years ago, relative to shareholder equity.
- ZNTL has $485.60M in cash and short term investments. This is enough to cover its annual cash burn of $208.41M.
- There are more short-term assets than short-term liabilities on the ZNTL balance sheet.
Is Zentalis Pharmaceuticals stock a Buy, Hold, or Sell, according to analysts?
Out of 4 sell side analysts who give forecasts on ZNTL, the consensus analyst rating on ZNTL is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Zentalis Pharmaceuticals stock forecast page.
ZNTL Technical Indicators
ZNTL Growth Metrics
Last year, ZNTL revenue was $0.00. During the past 5 year, ZNTL's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 28.49%.
You can research ZNTL's earnings and revenue performance here.
Are ZNTL insiders buying or selling the stock?
In the past 12 months, insiders at ZNTL have bought more shares than they have sold.
Melissa B. Epperly, Chief Financial Officer of ZNTL, was the latest ZNTL insider to sell. They sold $29,435.12 worth of ZNTL shares on Feb 12, 2024.
Learn more about who owns ZNTL shares here.
Can I get consistent income from ZNTL stock?
No, Zentalis Pharmaceuticals doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your ZNTL buy order
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly fine. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a given price, place a limit order.
Press the Open button and eToro will execute your order.
If you require more info about investing in stocks on eToro, watch the how to video below:
Step 6: Keep an eye on your ZNTL investment
Now that you own some ZNTL stock, you'll want to stay up-to-date on your stock purchase.
Start a watchlist to get the latest updates about your ZNTL stock.
ZNTL Feed
How to Buy Stock in Zentalis Pharmaceuticals
To reiterate, here are the 6 steps you need to take to buy Zentalis Pharmaceuticals stock right now:
- Choose where to buy Zentalis Pharmaceuticals stock
- Open your brokerage account
- Deposit funds into your brokerage account
- Evaluate Zentalis Pharmaceuticals stock
- Place your ZNTL buy order
- Keep an eye on your ZNTL investment
If you are looking for a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get the latest scoop on your investment in Zentalis Pharmaceuticals, click the button below.
More Stock Buying Guides You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.